UC Berkeley Launches New Molecular Therapeutics Initiative to Accelerate Drug Discovery

BERKELEY, Calif.–(BUSINESS WIRE)–The University of California, Berkeley Molecular Therapeutics (MTx) division of the Molecular & Cell Biology department today announced the launch of a new initiative to accelerate drug discovery at the interface of academia and biotech. The UC Berkeley Molecular Therapeutics Initiative (MTI) will create a foundational bridge between fundamental research in rare neurological and metabolic diseases and drug discovery to identify and accelerate novel therape
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks